| HIV-1 gag proteins: diverse functions in the virus life cycle EO Freed Virology 251 (1), 1-15, 1998 | 1112 | 1998 |
| Plasma membrane rafts play a critical role in HIV-1 assembly and release A Ono, EO Freed Proceedings of the National Academy of Sciences 98 (24), 13925-13930, 2001 | 917 | 2001 |
| HIV-1 assembly, release and maturation EO Freed Nature reviews microbiology 13 (8), 484-496, 2015 | 811 | 2015 |
| HIV-1 replication EO Freed Somatic cell and molecular genetics 26, 13-33, 2001 | 772 | 2001 |
| HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation MA Checkley, BG Luttge, EO Freed Journal of molecular biology 410 (4), 582-608, 2011 | 690 | 2011 |
| p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease M Huang, JM Orenstein, MA Martin, EO Freed Journal of virology 69 (11), 6810-6818, 1995 | 659 | 1995 |
| Phosphatidylinositol (4, 5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane A Ono, SD Ablan, SJ Lockett, K Nagashima, EO Freed Proceedings of the National Academy of Sciences 101 (41), 14889-14894, 2004 | 654 | 2004 |
| Viral late domains EO Freed Journal of virology 76 (10), 4679-4687, 2002 | 575 | 2002 |
| PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing F Li, R Goila-Gaur, K Salzwedel, NR Kilgore, M Reddick, C Matallana, ... Proceedings of the National Academy of Sciences 100 (23), 13555-13560, 2003 | 535 | 2003 |
| Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. EO Freed, DJ Myers, R Risser Proceedings of the National Academy of Sciences 87 (12), 4650-4654, 1990 | 530 | 1990 |
| Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions EO Freed, MA Martin Journal of virology 70 (1), 341-351, 1996 | 465 | 1996 |
| Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function DG Demirov, A Ono, JM Orenstein, EO Freed Proceedings of the National Academy of Sciences 99 (2), 955-960, 2002 | 457 | 2002 |
| Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency … EO Freed, MA Martin Journal of virology 69 (3), 1984-1989, 1995 | 426 | 1995 |
| Retrovirus budding DG Demirov, EO Freed Virus research 106 (2), 87-102, 2004 | 399 | 2004 |
| Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection EO Freed, G Englund, MA Martin Journal of virology 69 (6), 3949-3954, 1995 | 397 | 1995 |
| The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection (∗) EO Freed, MA Martin Journal of Biological Chemistry 270 (41), 23883-23886, 1995 | 390 | 1995 |
| Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production EO Freed, JM Orenstein, AJ Buckler-White, MA Martin Journal of virology 68 (8), 5311-5320, 1994 | 381 | 1994 |
| A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. EO Freed, EL Delwart, GL Buchschacher Jr, AT Panganiban Proceedings of the National Academy of Sciences 89 (1), 70-74, 1992 | 366 | 1992 |
| Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body A Ono, EO Freed Journal of virology 78 (3), 1552-1563, 2004 | 353 | 2004 |
| HIVs and their replication EO Freed Fields virology, 2107-2186, 2006 | 338 | 2006 |
